Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 04, 2026
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 21, 2025 in Zeta Global Holdings Corp. Lawsuit - ZETA
01:30pm, Wednesday, 04'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securitie
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 21, 2025 in Zeta Global Holdings Corp. Lawsuit - ZETA
12:30pm, Wednesday, 04'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, NY / ACCESSWIRE / December 4, 2024 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securitie
American Water Selects the American Red Cross for New York Stock Exchange's 2024 Global Giving Campaign
11:00am, Wednesday, 04'th Dec 2024
CAMDEN, N.J.--(BUSINESS WIRE)--American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., selects the American Red Cross to be recognized as part of the New Yo
Evelyn Dilsaver, Advisory Board member, honored on Directors list MENLO PARK, Calif. , Dec. 4, 2024 /PRNewswire/ -- Kim Bozzella, global leader of technology consulting for global consulting firm Prot
Navigating AI's Transformative Power in Labor, Energy and Society: S&P Global Publishes Latest Look Forward Journal
09:07am, Wednesday, 04'th Dec 2024
NEW YORK , Dec. 4, 2024 /PRNewswire/ -- S&P Global (NYSE: SPGI) today published the latest edition of its proprietary Look Forward research series, providing a comprehensive analysis of the comp
Zeta Global Reports 108% YoY Increase in Zeta Marketing Platform Usage During Start of Holiday Shopping Season
08:30am, Wednesday, 04'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Zeta Global (NYSE:ZETA), the AI-powered marketing cloud, today announced record-setting engagement for its Zeta Marketing Platform during the Cyber Five—the pivotal shoppi
Addition of 4x 2015/2016-built, immediately cash-generative post-panamax vessels, purchased from non-conventional seller at a 30+% discount to open-market charter-free values, consistent with strict i
LOS ANGELES--(BUSINESS WIRE)---- $TZUP #Advertising--Thumzup Media Corporation Announces AI Powered Innovation Implementation to its Disruptive Social Media Advertising Platform.
– Topline data for Phase 3 pivotal program anticipated in 2026 – WATERTOWN, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developin
Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader
07:00am, Wednesday, 04'th Dec 2024
CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the appo
State Street Global Advisors' 2025 Global Market Outlook: Finding the Right Path
06:30am, Wednesday, 04'th Dec 2024
BOSTON--(BUSINESS WIRE)--State Street Global Advisors, the asset management business of State Street Corporation (NYSE: STT), today launched its 2025 Global Market Outlook: Finding the Right Path, out
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Zeta Global Holdings Corp. - ZETA
01:26pm, Tuesday, 03'rd Dec 2024
NEW YORK , Dec. 3, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zeta Global Holdings Corp. ("Zeta" or the "Company") (NYSE: ZETA). Such investors are
Cboe Global Stock Lags Industry in 3 Months: Should You Buy?
12:35pm, Tuesday, 03'rd Dec 2024
CBOE's strategy of expanding product line across asset classes, broadening geographic reach and diversifying the business mix reflects operational expertise.
Understand the significant growth trajectory of the Gastrointestinal Diseases segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 28.7%. The Endocrine & Metabolic Disorders seg
